Immunovia AB
IMMNOV
Rangering i aksjer
#34535
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Aksjekurs
$0.00739046
Markedsverdi
$4.97M
Endring (1 dag)
-3.69%
Endring (1 år)
-78.59%
Land
SE
Handel Immunovia AB (IMMNOV)
Kategori
Healthcare
Aksjeprishistorikk for Immunovia AB (IMMNOV)
Høyeste sluttskurs: $0.01 den 2026-10-01
Laveste sluttskurs: $12.22 den 2018-01-01
Laveste sluttskurs: $12.22 den 2018-01-01
Aksjeprishistorikk for Immunovia AB fra 2018 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -27.09% |
| 2025 | -57.69% |
| 2024 | -60.72% |
| 2023 | -94.55% |
| 2022 | -61.46% |
| 2021 | -45.87% |
| 2020 | -13.27% |
| 2019 | -8.33% |
| 2018 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $678.35 | 19.60% |
US
|
|
| $229.46 | 5.21% |
US
|
|
| $398.58 | 111.99% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.76 | 19.12% |
US
|
